TOP

LOGIN
Products
Products
You are viewing the Global version of this page; click here for other versions.
Products Services Research

At Gen Re, we believe that information and collaboration are the basis for great innovation.

We leverage the actuarial, medical, and underwriting expertise of our global units with the market-specific knowledge of our regional departments to support your product initiatives.

Our product development support comprises a wide range of services needed by primary insurers, including design of new products, calculation of the respective rates, and development of policy terms and conditions. Post-launch, our portfolio monitoring and experience studies offer additional valuable insights.

Our Products

Card Image

Mortality

Card Image

Longevity

Card Image

Disability

Card Image

Critical Illness/
Dread Disease

Card Image

Health

Card Image

Long Term Care

Our Services

Underwriting

Our competent advice, comprehensive services, and effective tools and resources guide your risk management decisions.

Learn More

Claims

Our team of expert claim professionals develop effective claims management strategies specific to our clients’ needs.

Learn More

Market Research & Surveys

We produce marketplace surveys for our clients and the insurance industry. Clients also benefit from our individualized services including business monitoring.

Learn More

Analytics

We have a global network of data scientists, and deep expertise in solving complex business problems.

Learn More

Recent Research

Publication
Understanding Breast Cancer in Asia – Awareness and the Importance of Screening
Breast cancer ranks as the most prevalent cancer worldwide, and a staggering 2.3 million women were diagnosed with the illness globally in 2020. Although the prospects of survival in the battle against breast cancer are improving, the financial burden on patients remains significant. CI benefits can assist with managing the expenses.
Wendy Low, Pei Nee Yong, Samuel Lim October 19, 2023
Read More
Publication
Alzheimer’s Disease Overview – Detection and New Treatments
New anti-amyloid antibody treatments show promise in slowing Alzheimer’s progression in early stages. Challenges include identifying suitable patients, managing side effects, and overall evaluation of cost/benefit factors. Read a summary overview of the disease and details on emerging treatments.
Cecil Ramotar October 15, 2024
Read More
Publication
The Key Elements of Critical Illness Definitions for Mental Health Disorders
Critical illness insurance rarely covers mental health disorders despite their significant impact. We explore key elements for defining severe schizophrenia as a covered condition. Insurers can reduce stigma by offering comprehensive CI products with robust mental health benefits.
Sarah Hogekamp October 10, 2024
Read More
Publication
What Are We to Make of Cannabis Use in The Insured Population?
The use of cannabis as a medical treatment continues to grow, but how effective is this substance? We discuss various opinions and studies on the effectiveness of cannabis for certain conditions, and the importance of evidence-based risk frameworks for underwriters.
Dr. Chris Ball, Graeme Urquhart October 08, 2024
Read More
Publication
Gearing Up for Group Life Peak Season
For Group Life carriers, this is the season where Evidence of Insurability applications are on the rise – for some companies, 75% of annual applications are received and processed during “peak season”. Here’s a look at the main challenges and some underwriting suggestions.
Joe Iannetti September 25, 2024
Read More

Find an Expert in Your Region